Report cover image

Global Bottled Sodium Chloride Injection Market Growth 2025-2031

Published Oct 15, 2025
Length 122 Pages
SKU # LPI20471794

Description

The global Bottled Sodium Chloride Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Sodium Chloride Injection, which is mostly the 0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. Main ingredient of sodium chloride injection is sodium chloride. Sodium chloride is an electrolysis supplement agent. Sodium and chloride are important electrolysis for the human body and mainly exist in extracellular fluid, which play an important role in maintaining normal volume of blood, and extracellular fluid and osmosis pressure.

United States market for Bottled Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Bottled Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Bottled Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Bottled Sodium Chloride Injection players cover Baxter, Kelun Group, Fresenius Kabi, BBraun, Shijiazhuang No.4 Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Bottled Sodium Chloride Injection Industry Forecast” looks at past sales and reviews total world Bottled Sodium Chloride Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Bottled Sodium Chloride Injection sales for 2025 through 2031. With Bottled Sodium Chloride Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bottled Sodium Chloride Injection industry.

This Insight Report provides a comprehensive analysis of the global Bottled Sodium Chloride Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bottled Sodium Chloride Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bottled Sodium Chloride Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bottled Sodium Chloride Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bottled Sodium Chloride Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Bottled Sodium Chloride Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Plastic Bottle
Glass Bottle

Segmentation by Application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
Kelun Group
Fresenius Kabi
BBraun
Shijiazhuang No.4 Pharmaceutical
Hospira (ICU Medical)
CR Double-Crane
Otsuka
Cisen Pharmaceutical
Huaren Pharmaceuticals
Dubang Pharmaceutical
Zhejiang Chimin
Guizhou Tiandi
Qidu Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bottled Sodium Chloride Injection market?

What factors are driving Bottled Sodium Chloride Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bottled Sodium Chloride Injection market opportunities vary by end market size?

How does Bottled Sodium Chloride Injection break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

122 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Bottled Sodium Chloride Injection by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Bottled Sodium Chloride Injection by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.